Skip to content

诚信健康

US · ELV #242 按市值排名 上市于 1970
428.26 -0.17 -0.04%
实时 - 追踪5344个代码 - 心跳于448秒前 · 2026-10-16 20:02

最新新闻

  • UBS Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $460
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • 评级变动
    Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • 评级变动
    Jefferies Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $450
    \u5e02\u573a\u8d44\u8baf · 2026/7/16
  • Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488
    \u5e02\u573a\u8d44\u8baf · 2026/10/5
  • UBS Group Employee Benefits Survey: Elevance Health (ELV.US) Leads as U.S. Employers Prepare for Rising Healthcare Costs
    Zhitong Finance · 2026/9/14
  • 公司公告
    Bintai Kinden: Letter of Award for subcontract no. SCL171-001 for 6.B: Electrical Installation, 6.H : ELV Installation and 6.J : ICT Backbone in connection to the construction and completion of the Superstructure Main Contract Works for the Proposed Mixed
    Bursa Malaysia · 2009/2/20
  • RBC Capital Maintains Elevance Health(ELV.US) With Hold Rating, Cuts Target Price to $424
    \u5e02\u573a\u8d44\u8baf · 2026/10/9
  • 评级变动
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), Alnylam Pharma (ALNY) and Elevance Health (ELV)
    TipRanks · 2026/7/16
  • Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $469
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • 评级变动
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX)
    TipRanks · 2026/8/31
  • 公司公告
    Eduspec Holdings: Litespeed Education Technologies Berhad ("Litespeed" or the "Company") SALES AND PURCHASE AGREEMENT BETWEEN LITESPEED EDUCATION PTE LTD AND BAY WATCH ELV SYSTEM SDN. BHD. DATED 6 NOVEMBER 2006 ("TRANSACTION")
    Bursa Malaysia · 2006/11/10
  • 评级变动
    TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $465
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • 公司公告
    Eduspec Holdings: LITESPEED EDUCATION TECHNOLOGIES BERHAD ("LITESPEED" or "THE COMPANY") - SALES AND PURCHASE AGREEMENT BETWEEN LITESPEED EDUCATION PTE LTD ("LES"), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY AND BAY WATCH ELV SYSTEM SDN BHD (CO. NO.: 462497
    Bursa Malaysia · 2006/11/6
  • 评级变动
    BofA Securities Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $480
    \u5e02\u573a\u8d44\u8baf · 2026/9/11
  • 评级变动
    Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $488
    \u5e02\u573a\u8d44\u8baf · 2026/7/22
  • 评级变动
    Leerink Partners Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $395
    \u5e02\u573a\u8d44\u8baf · 2026/7/17
  • 评级变动
    A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $393 to $475
    \u5e02\u573a\u8d44\u8baf · 2026/7/16
  • 评级变动
    Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $457
    \u5e02\u573a\u8d44\u8baf · 2026/9/11
  • 评级变动
    Truist Financial Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $475
    \u5e02\u573a\u8d44\u8baf · 2026/7/14
  • 评级变动
    Wells Fargo Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $473
    \u5e02\u573a\u8d44\u8baf · 2026/9/15
  • Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488
    \u5e02\u573a\u8d44\u8baf · 2026/9/9
  • 评级变动
    A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $465 to $492
    \u5e02\u573a\u8d44\u8baf · 2026/7/14
  • 评级变动
    RBC Capital Maintains Elevance Health(ELV.US) With Hold Rating, Raises Target Price to $439
    \u5e02\u573a\u8d44\u8baf · 2026/7/9

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:30 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

诚信健康 讨论区 0 条评论

发表评论